Key facts
- Notable investors include Chinatorch InnoFund, Shicui Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Meiao Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Meiao Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Meiao Biotechnology
Manufacturer of biopharmaceutical products intended to advance stem cell applications and regenerative medicine. The company offers proprietary stem cell preservation, innovative biomedical manufacturing processes, and specialized biotechnology services, enabling hospitals, research institutions, and healthcare providers to enhance treatment options and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Nanchang, China
- Founded
- 2017
- Ownership
- Privately Held (backing)
Meiao Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Meiao Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Meiao Biotechnology in its N-PORT filings yet. We sweep new filings monthly.